These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 21804012)
1. Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases. Zaiss DM; Bekker CP; Gröne A; Lie BA; Sijts AJ J Immunol; 2011 Sep; 187(5):2302-9. PubMed ID: 21804012 [TBL] [Abstract][Full Text] [Related]
2. PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo. de Graaf N; van Helden MJ; Textoris-Taube K; Chiba T; Topham DJ; Kloetzel PM; Zaiss DM; Sijts AJ Eur J Immunol; 2011 Apr; 41(4):926-35. PubMed ID: 21360704 [TBL] [Abstract][Full Text] [Related]
3. Enhanced inflammatory potential of CD4+ T-cells that lack proteasome immunosubunit expression, in a T-cell transfer-based colitis model. Rasid O; Meulenbroeks C; Gröne A; Zaiss D; Sijts A PLoS One; 2014; 9(4):e95378. PubMed ID: 24740379 [TBL] [Abstract][Full Text] [Related]
4. The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion. Zaiss DM; de Graaf N; Sijts AJ Infect Immun; 2008 Mar; 76(3):1207-13. PubMed ID: 18160473 [TBL] [Abstract][Full Text] [Related]
5. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation. Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764 [TBL] [Abstract][Full Text] [Related]
6. The immunoproteasome in antigen processing and other immunological functions. Basler M; Kirk CJ; Groettrup M Curr Opin Immunol; 2013 Feb; 25(1):74-80. PubMed ID: 23219269 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i). Scheffler S; Kuckelkorn U; Egerer K; Dörner T; Reiter K; Soza A; Burmester GR; Feist E Rheumatology (Oxford); 2008 May; 47(5):622-6. PubMed ID: 18375405 [TBL] [Abstract][Full Text] [Related]
9. The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi. Ersching J; Vasconcelos JR; Ferreira CP; Caetano BC; Machado AV; Bruna-Romero O; Baron MA; Ferreira LR; Cunha-Neto E; Rock KL; Gazzinelli RT; Rodrigues MM PLoS Pathog; 2016 Apr; 12(4):e1005593. PubMed ID: 27128676 [TBL] [Abstract][Full Text] [Related]
10. Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice. Moebius J; van den Broek M; Groettrup M; Basler M Eur J Immunol; 2010 Dec; 40(12):3439-49. PubMed ID: 21108466 [TBL] [Abstract][Full Text] [Related]
11. Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. Basler M; Dajee M; Moll C; Groettrup M; Kirk CJ J Immunol; 2010 Jul; 185(1):634-41. PubMed ID: 20525886 [TBL] [Abstract][Full Text] [Related]
12. The antiviral immune response in mice devoid of immunoproteasome activity. Basler M; Beck U; Kirk CJ; Groettrup M J Immunol; 2011 Dec; 187(11):5548-57. PubMed ID: 22013127 [TBL] [Abstract][Full Text] [Related]
13. The proteasome activator REGγ counteracts immunoproteasome expression and autoimmunity. Yao L; Zhou L; Xuan Y; Zhang P; Wang X; Wang T; Meng T; Xue Y; Ma X; Shah AS; Shang S; Ma X; Xie W; Wang H; Fu Q; Xia Y; Moses RE; Wang H; Li L; Xiao J; Zhang B; Li X J Autoimmun; 2019 Sep; 103():102282. PubMed ID: 31171475 [TBL] [Abstract][Full Text] [Related]
14. Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome. Basler M; Maurits E; de Bruin G; Koerner J; Overkleeft HS; Groettrup M Br J Pharmacol; 2018 Jan; 175(1):38-52. PubMed ID: 29034459 [TBL] [Abstract][Full Text] [Related]
15. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. Caudill CM; Jayarapu K; Elenich L; Monaco JJ; Colbert RA; Griffin TA J Immunol; 2006 Apr; 176(7):4075-82. PubMed ID: 16547243 [TBL] [Abstract][Full Text] [Related]
16. Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. Deol P; Zaiss DM; Monaco JJ; Sijts AJ J Immunol; 2007 Jun; 178(12):7557-62. PubMed ID: 17548590 [TBL] [Abstract][Full Text] [Related]
17. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114 [TBL] [Abstract][Full Text] [Related]
18. The existence of two types of proteasome, the constitutive proteasome and the immunoproteasome, may serve as another layer of protection against autoimmunity. Eleftheriadis T Med Hypotheses; 2012 Jan; 78(1):138-41. PubMed ID: 22070888 [TBL] [Abstract][Full Text] [Related]
19. CD8+ T-cell auto-reactivity is dependent on the expression of the immunoproteasome subunit LMP7 in exposed to lipopolysaccharide antigen presenting cells and epithelial target cells. Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I Autoimmunity; 2013 Nov; 46(7):439-45. PubMed ID: 23763593 [TBL] [Abstract][Full Text] [Related]
20. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8. Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]